Skip to content

GRAIL, Inc. GRAL Total Cost of Revenue

Total Cost of Revenue at other companies

Abbott logo
AbbottABT
$4.89B+9.4%
Guardant Health logo
Guardant HealthGH
$104.92M+40.4%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$18.71M+10.2%
GeneDx Holdings logo
GeneDx HoldingsWGS
$34.04M+18.9%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$29.29M+39.5%
Natera, Inc. logo
Natera, Inc.NTRA

Segments

By product

See full
Screening revenue$21.24M+24.1%
Development Services$376K-67.9%

Other financials

Income statement

See full
Revenue$40.8M+28.1%
Operating income-$135.8M+11.6%
Net income-$93.2M+12.3%
EPS (diluted)-$2.29+26.1%

Balance sheet

See full
Cash & equivalents$76.3M-44.4%
Total debt$51.0M-20.7%
Total equity$2.5B+3.6%
Total assets$2.8B-1.5%

Cash flow

See full
Operating cash flow-$87.0M+8.4%
CapEx$503.0K+711%
Free cash flow-$87.5M+8.0%

Valuation

See full
Market cap$2.77B+145%

Profitability

See full
Operating margin-348.7%-153pp
Net margin-253.2%-115pp
FCF margin-187.2%-60.4pp

Returns & leverage

See full
Return on equity-16.1%
Debt / equity0.0×
Current ratio11.7×+2.0×

Questions, answered.

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.